Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 3/20 | 0.49 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.46 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RARB | P10826 | 3/20 | 0.45 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29638853 | 1.00 | PTPN11 (0.49) | PTPN11NR5A1NPC1LMNAMAPT | |
| SCHEMBL6521580 | 1.00 | PTPN11 (0.49) | PTPN11NR5A1NPC1LMNAMAPT | |
| SCHEMBL3813335 | 0.96 | NPC1 (0.50) | PTPN11NPC1LMNAMAPTCNR1 | |
| SCHEMBL23285271 | 0.94 | PTPN11 (0.46) | PTPN11NR5A1NPC1LMNAMAPT | |
| SCHEMBL26915684 | 0.92 | PTPN11 (0.50) | PTPN11NR5A1NPC1LMNAMAPT | |
| SCHEMBL29364333 | 0.90 | PTPN11 (0.49) | PTPN11NR5A1NPC1MAPTCNR2 | |
| SCHEMBL3675957 | 0.90 | PTPN11 (0.49) | PTPN11NR5A1NPC1MAPTCNR2 | |
| SCHEMBL4413556 | 0.90 | PTPN11 (0.49) | PTPN11NR5A1NPC1MAPTCNR2 | |
| SCHEMBL39014 | 0.90 | PTPN11 (0.49) | PTPN11NR5A1NPC1MAPTCNR2 | |
| SCHEMBL7894761 | 0.90 | PTPN11 (0.49) | PTPN11NR5A1NPC1MAPTCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9949475-B2 | Composition comprising active ingredient, oil and ionic liquid | BASF SE (DE) | 2018-04-24 | — | — | US | claimed |
| US-8173729-B2 | Photosensitive resin composition | DONGJIN SEMICHEM CO., LTD. (KR) | 2012-05-08 | — | — | US | claimed |
| US-20100222473-A1 | PHOTOSENSITIVE RESIN COMPOSITION | DONGJIN SEMICHEM CO., LTD. (KR) | 2010-09-02 | — | — | US | claimed |
| JP-9188666-A | — | — | None | — | — | JP | disclosed |
| US-12569414-B2 | Sunscreen compositions containing porous metal oxide spheres | BASF SE (DE) | 2026-03-10 | — | — | US | disclosed |
| US-20250099345-A1 | UV FILTER COMPOSITIONS COMPRISING CLOSED-CELL METAL OXIDE PARTICLES | BASF SE (DE) | 2025-03-27 | — | — | US | disclosed |
| US-20250090429-A1 | UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES | BASF SE (DE) | 2025-03-20 | — | — | US | disclosed |
| EP-4465950-A1 | UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES | BASF SE (DE) | 2024-11-27 | — | — | EP | disclosed |
| EP-4465949-A1 | UV FILTER COMPOSITIONS COMPRISING CLOSED-CELL METAL OXIDE PARTICLES | BASF SE (DE) | 2024-11-27 | — | — | EP | disclosed |
| US-20240254096-A1 | ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS | ELKIMIA INC (CA) | 2024-08-01 | — | — | US | disclosed |
| EP-3458162-B1 | MICRO-PARTICULATE ORGANIC UV ABSORBER COMPOSITION | BASF SE (DE) | 2024-07-10 | — | — | EP | disclosed |
| WO-2003029359-A1 | CATIONIC REACTIVE DYES | CIBA SPECIALTY CHEMICALS HOLDINGS INC. (CH) | 2003-04-10 | — | — | WO | disclosed |
| WO-2003024417-A1 | USE OF GUAIOL FOR TREATING THE SKIN | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-03-27 | — | — | WO | disclosed |
| WO-2003022790-A2 | BIPHENYLENE COMPOUNDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003016289-A1 | TRIAZINE DERIVATIVES AND THEIR USE AS SUNSCREENS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-02-27 | — | — | WO | disclosed |
| EP-1232148-A1 | USE OF BENZOTRIAZOLE UV ABSORBERS | Ciba SC Holding AG (CH) | 2002-08-21 | — | — | EP | disclosed |
| WO-2001036396-A1 | USE OF BENZOTRIAZOLE UV ABSORBERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-05-25 | — | — | WO | disclosed |
| US-5955060-A | COSMETICS AND VETERINARY MEDICINE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-09-21 | — | — | US | disclosed |
| JP-H09188666-A | BIS(RESOLCINYL)TRIAZINE | CIBA GEIGY AG | 1997-07-22 | — | — | JP | disclosed |
| EP-0775698-A1 | Bis-resorcinol-triazines as UV absorber triazine | Ciba SC Holding AG (CH) | 1997-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099345-A1 | UV FILTER COMPOSITIONS COMPRISING CLOSED-CELL METAL OXIDE PARTICLES | SUN2, ERCC4, XPA | PTPN11 3378/4885NR5A1 3085/4885NPC1 1189/4885 |
| US-20250090429-A1 | UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES | ERCC4, SUN2, ERCC5 | PTPN11 3264/4885NR5A1 2992/4885NPC1 1320/4885 |
| US-20240254096-A1 | ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS | ERCC1, ERCC4, ERCC5 | PTPN11 2273/4885NR5A1 2555/4885NPC1 3671/4885 |
| US-12569414-B2 | Sunscreen compositions containing porous metal oxide spheres | RAD50, CTSA, MCM7 | PTPN11 1668/4885NR5A1 2245/4885NPC1 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.